Walleye Trading’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Walleye Trading’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-9,200	Closed	-$1.09M	–	5815
2021 Q1	$1.09M	Sell	9,200 -800	-8%	-$94.6K	﹤0.01%	1842
2020 Q4	$1.18M	Buy	10,000 +4,800	+92%	+$557K	0.01%	1830
2020 Q3	$578K	Sell	5,200 -1,400	-21%	-$150K	﹤0.01%	2117
2020 Q2	$674K	Buy	6,600 +1,700	+35%	+$182K	﹤0.01%	2008
2020 Q1	$529K	Sell	4,900 -4,000	-45%	-$460K	﹤0.01%	1828
2019 Q4	$1.04M	Buy	8,900 +5,700	+178%	+$660K	0.01%	1773
2019 Q3	$366K	Sell	3,200 -24,500	-88%	-$2.44M	﹤0.01%	2427
2019 Q2	$2.64M	Buy	+27,700	New	+$2.61M	0.02%	845

Walleye Trading's CBPO Position: Q4 2020 in Review

Walleye Trading sold out of China Biologic Products Holdings, Inc. (CBPO) in Q4 2020, closing a stake of 230 shares — an estimated $26.7K sold.

Walleye Trading first reported a position in CBPO in Q2 2015 and held it in 6 quarters. The position peaked at $357K in Q3 2019. 89 funds tracked by Wall St. Rank hold CBPO as of Q4 2020.

Walleye Trading reported no remaining China Biologic Products Holdings, Inc. position as of Q4 2020 after selling out during the quarter.
Walleye Trading sold 230 China Biologic Products Holdings, Inc. shares in Q4 2020, an estimated $26.7K.
Walleye Trading first reported a position in China Biologic Products Holdings, Inc. in Q2 2015 and held it in 6 quarters.
Walleye Trading's China Biologic Products Holdings, Inc. position peaked at $357K in Q3 2019.
89 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q4 2020.

Based on Walleye Trading's 13F filing for Q4 2020, filed 16 Feb 2021.